Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2821 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4709 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-543 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate |
2010-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c717bf5fee4513c52de0da3bdf211c88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c675d1858dacec95639b817e0f4c496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88785b672c52d3be399d77cbf725d673 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd113102e219d5ee8df2699046b7407e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36b19569748143ba837a40fea9d336ad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c43f38b9a8895e1877650da940c43ba |
publicationDate |
2012-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20120116416-A |
titleOfInvention |
Amyloid Beta Aggregates As Biomarkers for Alzheimer's Disease in Cerebrospinal Fluid |
abstract |
The present invention provides a method of evaluating increased probability of developing Alzheimer's disease in a subject under assessment, comprising obtaining a measurement of Aβ40 aggregate in a biological sample of the subject, wherein the biological sample is a brain tissue, a fragment of brain tissue. Or brain homogenate. In some embodiments, the present invention relates to a method of assessing increased probability of early stage of Alzheimer's disease. The present invention provides a method for assessing increased probability of not having Alzheimer's disease, a method for observing disease progression in a subject with Alzheimer's disease, and a method for determining the stage of the disease for a subject having Alzheimer's disease, and progressing to Alzheimer's disease. It provides a method for evaluating increased probability of MCI. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014175693-A1 |
priorityDate |
2009-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |